Molecular and biochemical mechanisms of bile duct injury after liver transplantation by Buis, Carlijn Ineke
  
 University of Groningen
Molecular and biochemical mechanisms of bile duct injury after liver transplantation
Buis, Carlijn Ineke
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2008
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Buis, C. I. (2008). Molecular and biochemical mechanisms of bile duct injury after liver transplantation.
Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the






The role of bile salt toxicity in the  
pathogenesis of bile duct injury after non 












Bile salt toxicity and bile duct injury after NHB porcine liver transplantation Chapter 5
Abstract
Background. Intrahepatic bile duct strictures are a serious complication after non-heart-
beating (NHB) liver transplantation. Bile salt toxicity has been identified as an important factor 
in the pathogenesis of bile duct injury and cholangiopathies. The role of bile salt toxicity in the 
development of biliary strictures after NHB liver transplantation is unclear. 
Methods. In a porcine model of NHB liver transplantation, we studied the effect of different 
periods of warm ischemia in the donor on bile composition and subsequent bile duct injury 
after transplantation. After induction of cardiac arrest in the donor, liver procurement was 
delayed for 0 min (group A), 15 min (group B) or > 30 min (group C). Livers were subsequently 
transplanted after four hours of cold preservation. In the recipients, bile flow was measured 
and bile samples were collected daily to determine the bile salt / phospholipid ratio. Severity 
of bile duct injury was semi-quantified by using a histological grading scale. 
Results. Posttransplant survival was directly related to the duration of warm ischemia in 
the donor. The bile salt / phospholipid ratio in bile produced early after transplantation was 
significantly higher in group C, compared to group A and B. Histopathology showed the highest 
degree of bile duct injury in group C. 
Conclusion. Prolonged warm ischemia in NHB donors is associated with the formation of 
toxic bile after transplantation, with a high biliary bile salt / phospholipid ratio. These data 





The success of orthotopic liver transplantation as a therapy for patients with end-stage liver 
disease has resulted in an increasing demand for donor livers. In many parts of the world this 
created a growing shortage of organs from brain death or deceased donors. A possible solution 
to reduce shortage of donor organs is expansion of the donor pool by accepting donation after 
cardiac death (DCD) or non-heart-beating (NHB) donors. Patient survival after transplantation 
of livers from NHB donors has shown to be comparable to survival after transplantation of 
livers from brain death donors (1-4). Graft survival after NHB liver transplantation, however, 
is about 10-15% lower due to a higher rate of primary non-function and other graft-related 
complications. Intrahepatic bile duct strictures, also known as non-anastomotic strictures or 
ischemic-type biliary lesions, are a serious cause of morbidity and a leading cause of graft 
failure after NHB liver transplantation (5-7). Although the exact pathogenesis is unknown, it is 
generally believed that warm ischemia in the NHB donor due to hypotension before cardiac 
arrest, as well as during the time period between cardiac and organ procurement, is a critical 
factor in the pathogenesis of these biliary strictures (5-7). Although hepatocytes may recover 
from the warm ischemic insult in donor, bile duct epithelial cells have a poor tolerance towards 
ischemia and regeneration of cellular ATP is much slower than in hepatocytes (8-12). Apart from 
this direct detrimental effect of ischemia on the bile duct epithelium (13), there is accumulating 
evidence that bile salt toxicity contributes to bile duct injury after liver transplantation (14-
16). Although secretion of bile salts by hepatocytes is the main driving force of bile flow, bile 
salts can act as detergents injuring cellular phospholipid membranes. Under physiological 
circumstances, bile salts are therefore neutralized in bile by phospholipids after formation of 
mixed micelles (17).
Experimental studies in mice as well as clinical studies in humans have indicated that bile 
formation early after liver transplantation may be disturbed, resulting in the formation of more 
toxic bile with a relatively high bile salt / phospholipid ratio. A high bile salt / phospholipid ratio 
has been associated with more severe bile duct injury after transplantation (14-16). 
The role of bile salts in the pathogenesis of bile duct injury after NHB liver transplantation has not 
been studied before. We hypothesized that bile salt toxicity acts in concert with warm ischemia 
injury in the pathogenesis of intrahepatic bile duct injury after NHB liver transplantation. To study 
the role of bile salts in the development of bile duct injury after NHB liver transplantation, we 
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have used a well established model of NHB liver transplantation in pigs (18,19). The specific 
aim was to study whether increasing length of warm ischemia in NHB donors is associated with 
more toxic bile formation after transplantation, as indicated by the bile salt / phospholipid ratio, 
and subsequently more severe injury of the intrahepatic bile ducts. 
Materials and Methods
Animals and NHB Liver Transplant Model 
Inbred female Landrace pigs, weighing 18 to 37 kg, were used as donors and recipients. 
In donors, cardiac arrest was induced by ventricular fibrillation, followed by standardized 
periods of warm ischemia before cold preservation and procurement of the liver, to mimic 
NHB donation. The pigs were divided in 5 groups (n=6 each) with different periods of donor 
warm ischemia time (WIT): 0 min (controls; group A), 15 min (group B), and 30, 45 or 60 
minutes. Because of a low rate of survivors in the latter three subgroups (2/6, 2/6, and 0/6 
at postoperative day 4, respectively) we regarded these as one group for analysis (group C, 
> 30 min WIT). In general, there were no major differences in outcome parameters between 
these three groups. 
After the period of warm ischemia, the liver was flushed with ice cold histidine tryptophan 
ketoglutarate (HTK) preservation solution. During cold perfusion, a cholecystectomy was 
performed and the common bile duct was transected and flushed out with cold saline solution. 
Subsequently, livers were stored at 4˚C for four hours until transplantation. 
In the recipients, a midline laparotomy was performed, the native liver was removed, and the 
donor liver was implanted in an orthotopic position. No veno-venous bypass was used. After 
completing the anastomosis between the suprahepatic inferior vena cava of the recipient 
and donor, the portal vein was reconstructed and the liver was reperfused. Subsequently, the 
infrahepatic vena cava was reconstructed. Arterial recirculation was established by an end-to-
side anastomosis between the donor aorta (left in continuity with the hepatic artery) and the 
recipient aorta. There were no significant differences in the duration of the anhepatic time or 
the time interval between portal reperfusion and restoration of arterial blood low among the 
three groups. Mean (range) duration of the anhepatic phase in group A, B and C was 23 min 
(20-26 min), 25 min (20-30 min), and 24 min (18-30 min), respectively. Time interval between 
portal and arterial reperfusion was 38 min (30-45 min), 42 min (28-68 min), and 37 min (20-
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68 min), respectively. Flow probes (Transonic Systems, Ithaca, NY, USA) were implanted 
around the hepatic artery and portal vein and connected to a dual channel ultrasonic transit-
time volume flow meter (T206, Transonic). Blood flow was measured continuously during the 
first 3 hours after reperfusion and twice daily thereafter. In addition, patency of the vascular 
anastomoses was macroscopically inspected during necropsy. All hepatic artery anastomoses 
were found to be patent. 
Perioperatively, arterial blood pressure was monitored via an arterial line in the left common 
carotid artery. Central venous pressure was monitored via a catheter in the left external jugular 
vein. Infusion of intravenous fluids was individually guided by clinical signs of hypovolemia, 
hemodynamic parameters, and laboratory blood analysis. Although moderate hypotension up 
to a period of 30 min was well tolerated during the anhepatic phase, 500 ml of oxyplatin was 
administered IV during the anhepatic phase to avoid severe hypotension  (20). In general, 
there were no major differences in hemodynamics among the groups. 
During transplantation a catheter was inserted in the common bile duct and externalized via 
the abdominal wall. Daily bile production was completely diverted into a collecting bag. To 
maintain the enterohepatic circulation of bile salts, bile was readministered via a jejunostomy 
catheter. Antibiotic prophylaxis was provided by IV Ceftazidime, 500 mg.
Postoperatively, animals received tacrolimus (0.05 mg/kg bid) as immunosuppressant. All 
animals had free access to water and food. All surviving animals were able to feed themselves 
normally as of postoperative day 2 and there were no apparent differences between the groups. 
The postoperative observation period was limited to four days to minimize confounding effects 
caused by sepsis and other late-onset phenomena. After four days the pigs were killed and 
animals surviving less than four days were autopsied to identify the cause of death (19). 
Experiments were performed in accordance with the Belgian law regarding animal welfare.
Biochemical serum analyses
Serum levels of aspartate aminotransferase (AST) and bilirubin were determined using routine 
chemical methods.
Collection of Bile and Determination of Bile Composition
Bile production was measured 3 hours after reperfusion and daily thereafter to calculate bile 
flow (bile production / kg body weight of the donor). Bile samples were collected daily to 
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examine bile composition and determination of the biliary bile salt / phospholipid ratio. Total 
biliary bile salt concentration was measured spectrophotometrically using 3α-hydroxysteroid 
dehydrogenase (21). Biliary phospholipid concentration was analysed using a commercially 
available enzymatic method (Wako Chemicals GmbH, Neuss, Germany).
Hepatic Gene Expression of Bile Transporters
In parallel with the measurement of bile composition, we measured hepatic mRNA expression 
of the bile salt transporter (bile salt export pump; BSEP or Abcb11) and the phospholipid 
translocator (multidrug resistance protein; MDR3 or Abcb4). The gene sequence of porcine 
MDR3 was not known and, therefore, determined for this experiment (NCBI Accession #: 
EF067318).  
Wedge biopsies were taken one hour after reperfusion and on postoperative day (POD) four 
in surviving animals.  Biopsies were snap frozen and stored at -80° C until analysis. RNA 
isolation from liver biopsies was performed using TRIzol (Invitrogen Life Technologies, Breda, 
The Netherlands), Chloroform (Merck, Darmstadt, Germany) and the DNAse-kit from Sigma 
(Sigma-Aldrich, Zwijndrecht, The Netherlands). RNA integrity was quantified by electrophoresis 
using agarose-gel (Sphaero Q, Leiden, The Netherlands) and ethidiumbromide (Sigma-
Aldrich). The enzyme M-MLV reverse transcriptase (Sigma-Aldrich) was used to convert 
RNA (1µg in a final volume of 21 µl) in copy-DNA (cDNA). Taq polymerase (Invitrogen Life 
Technologies, Breda, The Netherlands) and conventional PCR were used to multiply the cDNA 
and make it detectable with DNA electrophoresis by an UV-transilluminator. For quantitative 
real-time detection, sense, anti-sense porcine primers (Invitrogen, Paisley, Scotland) and 
fluorogenic probes (Eurogentec, Herstal, Belgium) were designed for the hepatobiliary 
transporters BSEP and MDR3, using Primer Express software (PE Aplied Biosystems, Foster 
City, CA, USA). All probes were 5’ labeled by a 6-carboxy-fluorescein (FAM) reporter and 3’ 
labeled with a 6-carboxy-tetramethyl-rhodamine (TAMRA) quencher (table 1). In each PCR 
reaction duplicate samples of 5 µl cDNA (25x) (2 ng RNA / µl) were used in a final volume 
of 20 µl (qPCR Core Kit Eurogentec, Seraing, Belgium). Every PCR sample was duplicated 
in triplo, in a real-time RT PCR 384 wells plate  (Applied Biosystems). mRNA copy numbers 
of transporter genes were normalized to those of porcine β-actine mRNA. The ABI PRISM 
7700 sequence detector (Applied Biosystems) was used for quantitative real-time RT PCR 
according to the manufacturer’s instructions. 
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Histopathological Grading of Bile Duct Injury
Bile duct injury in biopsies taken during and after transplantation was semiquantified by 
calculating a modified bile duct injury severity score (BDISS) as described previously (21), and 
based on the following two components: bile duct epithelial damage (graded as 0 = absent, 1 
= mild, 2 = moderate, 3 = severe; modified from the Banff criteria for acute rejection (22)) and 
ductular reaction (graded as 0 = absent, 1 = mild, 2 = moderate, 3 = severe). This resulted in 
a minimal BDISS of 0 and a maximum score of 6 points. All histological assessments were 
performed by a single pathologist (ASG) who was unaware of the study group of the animals 
and of the other study data.
Statistics
Values are expressed as mean ± standard error of the mean (SEM). Data were analyzed 
using SPSS software version 14.0 for Windows (SPSS Inc., Chicago, Il, USA). Differences 
within and between groups were compared using a paired and non-paired Student-T test, 
respectively. Total course of biochemical variables during the first week was compared by 
calculating the area under the curve (AUC, using the trapezium rule). All p-values were two-
tailed and considered statistically significant at a level of less than 0.05.
Results
Survival Analysis
Postoperative survival of animals was directly related to the duration of warm ischemia in the 
donor (figure 1). In the group A (0 min donor WIT), four days survival rate was 100%, compared 
to 90% in the group B (15 min donor WIT) and 20% in group C (> 30 min donor WIT). 
In group B, one recipient was found death on POD 1, despite a good initial recovery from the 
transplant procedure. On necropsy, death was contributed to hypoxia resulting from severe 
pulmonary edema. In group C, one animal was awake and recovering from the procedure, 
but could not be weaned from the ventilator, due to lack of spontaneous respiratory activity, 
possibly as a result of brain stem injury. In accordance with the international guidelines on 
animal welfare, this animal was sacrificed 12 hours after surgery. One animal recovered 
from the procedure, but was found death on POD 1. A subsequent necropsy did not reveal 
a clear cause of death (normal aspect of all thoraco-abdominal organs, no ascites, and no 
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other indications of liver failure). The remaining animals that died were diagnosed with early 
postoperative liver failure or primary graft non-function. Usually, these animals displayed an 
incorrectable metabolic acidosis with increasing levels of lactate and severe coagulopathy 
after reperfusion, and could not be weaned from the ventilator. On necropsy, typically, large 
amounts of hemorrhagic ascites were found as a result of the severe coagulopathy and portal 
hypertension due to congestion in failing liver. 
In parallel with the clinical course, serum levels of AST at 3 hrs after reperfusion were 
significantly higher in group C, compared to group B and A (1938+170, 1116+520 and 288+58 
U/L, respectively; p<0.05). However, there were no significant differences in serum AST levels 




























Early Recovery of Bile Flow and Bile Composition
Animals which died immediately postoperative from early graft failure (mainly in group C) 
displayed very minimal or no bile production and, therefore, were not included in the bile 
analyses. Bile flow at 3 hr and 24 hr after graft reperfusion was significantly lower in the 
surviving animals in group C (> 30 min WIT) compared to the control group A, while there was 
no significant difference in bile flow recovery between the group B (15 min WIT) and the control 
group A (figure 2). The composition of bile produced by livers with a WIT > 30 min (group C) 
was also more cytotoxic, as expressed by a significantly higher bile salt / phospholipid ratio 
early after transplantation (figure 3). Serum bilirubin levels increased during the postoperative 
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Figure 2. Bile flow after NHB liver transplantation in relation to various time periods of warm ischemia in the donor. 
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Figure 3. Mean biliary bile salts / phospholipid (BS / PL) ratio during four days after NHB liver transplantation. 
AUC, area under the curve. 
Histological Evaluation of Bile Duct Injury
In the surviving animals, histological analysis of postoperative liver biopsies showed a higher 
degree of bile duct injury in livers with prolonged warm ischemia in the donor. There were no 
differences in the mean BDISS in the group of livers with a WIT of 0 min (group A), compared 
to the group with WIT of 15 min (group B).  However, the BDISS was significantly higher in 
the group with a WIT > 30 min (group C) compared to the groups A and B together (3.0 + 0.2 
versus 2.2 + 0.2; p= 0.013). Representative examples of histology of liver biopsies with a low, 






Figure 4. Representative examples of histology of liver biopsies (Masson Trichrome staining). A) Low BDISS: a 
portal tract showing a bile duct with mild epithelial damage, loss of nuclei and infiltration by a neutrophilic gran-
ulocyte. B) Intermediate BDISS: a portal tract containing inflammatory cells. A hepatic artery is shown on the 
left and a bile duct on the right side. The damaged bile duct shows epithelial desquamation (lumen), infiltration 
by inflammatory cells and disruption of the basement membrane (arrows). There is nuclear atypia, stratification 
and loss of biliary epithelial cells. C) High BDISS: a portal tract showing severely damaged and malformed bile 
ducts (arrows). There is loss of and diffuse damage to epithelial cells, disrupted basement membrane and heavy 
infiltration by inflammatory cells.
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Gene Expression of Bile Transporters
Hepatic expression of BSEP and MDR3 mRNA decreased after transplantation in all three 
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Figure 5. Relative BSEP (A) and MDR3 (B) mRNA levels in porcine liver grafts after 0 min, 15 min or > 30 min WIT. 
Biopsies were taken at 0 min, 60 min and 4 days after transplantation. Genes of interest were standardized for β-actin 
mRNA. 
Discussion
The aim of this study was to investigate whether prolonged warm ischemia in NHB donors 
is associated with the production of more toxic bile early after transplantation, which may 
subsequently contribute to the development of intrahepatic biliary strictures after NHB liver 
transplantation. In a porcine model of NHB liver transplantation we have shown that livers 
obtained from donors who suffered > 30 min of warm ischemia produced bile with a significantly 
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higher bile salt / phospholipid ratio after transplantation than livers from donors with 0 or 15 min 
warm ischemia in the donor. In addition, bile duct injury was more severe and the survival rate 
was lower the group with > 30 min of warm ischemia in the donor. These findings indicate that 
prolonged warm ischemia in the NHB donor is associated with the posttransplant production 
of cytotoxic bile, characterized by a high biliary bile salt / phospholipid ratio, and suggest that 
these changes in bile composition contribute to the pathogenesis of bile duct injury after NHB 
liver transplantation. 
The current findings are in accordance with previous experimental and clinical studies, 
which indicated that bile salts contribute to the development of bile duct injury after liver 
transplantation (15,23,24). Although the secretion of bile salts by hepatocytes into the bile 
canaliculus is the main driving force behind the generation bile flow, bile salts are also 
potentially cytotoxic due to their detergent activity (17). Under normal conditions, bile salts 
form mixed micelles with phospholipids and cholesterol, which prevents bile salt toxicity. In 
case of excess of bile salts, either due to increased bile salt secretion or reduced secretion 
of phospholipids, free non-micellar bile salts may cause cholangiocyte injury, pericholangitis 
and periductal fibrosis (17,25). In human liver transplantation, it has been shown that bile 
salt secretion recovers more rapidly after liver transplantation than phospholipid secretion, 
resulting in a cytotoxic bile composition (14). A high bile salt / phospholipid ratio early after 
transplantation is correlated with the histological degree of bile duct injury. In an experimental 
mouse model of liver transplantation it was recently shown that livers from Mdr2 +/- mice, 
which secrete only 50% of the normal amount of phospholipids into the bile, develop severe 
bile duct injury after transplantation, as reflected by enlarged portal tracts with cellular damage, 
ductular proliferation, bile stasis and a dense inflammatory infiltrate (16). In contrast, no such 
abnormalities were seen in transplanted wild-type mouse livers. In addition to these studies, 
which focussed on the detrimental effects of endogenous bile salts, others have shown similar 
deleterious effects of exogenous administered bile salts. Experimental studies in pigs have 
shown that infusion of hydrophobic bile salts before liver procurement results in significantly 
increased intrahepatic biliary injury after transplantation, compared to control livers flushed 
with saline (15). The observed high biliary bile salt / phospholipid ratio early after NHB liver 
transplantation in the current study, suggest that bile salt toxicity is a contributing factor in the 
development of bile duct injury after NHB liver transplantation. The bile salt / phospholipid 
ratio correlated well with the length of warm ischemia due to cardiac arrest in the donor. It 
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is likely that the ischemic insult to the biliary epithelium remains a key determinant in the 
pathogenesis bile duct injury after NHB liver transplantation, however, bile salt toxicity could 
aggravate the degree of injury.  
Hepatobiliary secretion of bile salts and phospholipids is an active process which is determined 
by the hepatic transporters BSEP and MDR3, respectively. Various molecular changes of 
hepatocellular-transport systems have been described in patients with cholangiopathy or 
cholestatic disorders (17), illustrating the importance of these transporter functions. Decreased 
activity of the MDR3 (26-28) or BSEP (29) transporters, due to a gene mutation for example, 
is associated with decreased bile formation and cholestasis. In our study we observed a 
reduction in the expression of BSEP and MDR3 mRNA after transplantation. However, no 
significant differences were noted between the three groups. These data are in accordance 
with a recent study in human livers from heart-beating (deceased) donors where also no 
differences were found in BSEP and MDR3 mRNA expression at three hours after graft 
reperfusion (13). In this human study, however, a small, but significant, increase in BSEP 
expression was found at one week after transplantation (14). Follow-up in our study was limited 
to only four days and further studies will be needed to determine whether similar changes also 
occur in this porcine model of NHB donor liver transplantation. In general, current findings 
suggest that the observed differences in bile composition are caused by posttranscriptional 
processes or changes in transporter activity rather than a direct effect on gene transcription. 
It is increasingly recognized that changes in protein levels of BSEP and NTCP are largely 
determined by the subapical storage or mobilization of these transporter proteins and to a 
lesser degree by changes in gene expression (30). Unfortunately, we were unable to perform 
immunohistochemistry or western blot analyses, due to the lack of adequate antibodies 
against porcine BSEP and MDR3. 
The accumulating evidence supporting the concept of bile salt toxicity as an important 
determinant in the pathogenesis of bile duct injury after liver transplantation opens new 
avenues for preventive and therapeutic measures. One obvious option would be the exogenous 
administration of hydrophilic bile salts, such as ursodeoxycholic acid, which lack the detergent 
properties of hydrophobic bile salts. Daily oral administration of ursodeoxycholic acid is a well 
known therapy to reduce bile salt toxicity by replacement of the hydrophobic bile salts in the 
bile salt pool (31,32). In addition, hydrophilic bile salts have been shown to possess more direct 
cytoprotective properties which are independent from the reduction in hydrophobic bile salts, 
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and involve inhibition of apoptotic pathways (15,31). Another interesting therapeutic target 
could be MDR3, given the key role of biliary phospholipids in protecting bile duct epithelium 
from potentially toxic, aggressive biliary content (30). Therapeutic strategies aimed at reducing 
bile toxicity through stimulation of MDR3 expression and function may be an important future 
therapeutic approach to prevent bile duct injury after liver transplantation. Administration of 
fibrates, statins or peroxisome proliferators, have been shown to stimulate biliary phospholipid 
secretion by the induction of MDR3 (or its rodent homolog mdr2), making bile less toxic (33-
35). However, more research in this area, including assessment of potential side effects of 
these compounds will be needed before clinical application of these compounds to prevent 
bile duct strictures can be advised.
Currently, there is not an established animal model of bile duct injury after NHB-donor liver 
transplantation. Development of such a model, however, is of great relevance to facilitate 
studies on the pathogenesis and development of biliary strictures in liver grafts from NHB 
donors. In the current study we have focussed on injury of the small (microscopic) bile ducts 
in the liver parenchyma. In clinical practice, bile duct lesions in livers from NHB donors are 
typically found in the larger (macroscopic) bile ducts (9). More research using the current 
porcine model with more longterm follow-up will be needed to determine whether bile salt 
toxicity is also involved in the development of bilary strictures in the larger bile ducts. The ideal 
model of NHB liver donation is one in which the time period of cardiac arrest results in a timely 
recoverable hepatocellular injury (an thus animal and graft survival), but yet the developement 
of enough biliary damage to develop biliary strictures more longterm after transplantation. In 
this respect, 30 minutes of donor warm ischemia appeared to be a useful model for further 
research. 
In summary, we investigated the role of toxic bile composition in the pathogenesis of bile 
duct injury after NHB liver transplantation, using a well established porcine model. Our data 
indicate that the length of warm ischemia due to cardiac arrest in the NHB donor correlates 
with the formation of toxic bile, characterized by a high biliary bile salt / phospholipid ratio, after 
transplantation. These findings suggest that bile salt toxicity contributes to the pathogenesis 
of bile duct injury after NHB liver transplantation. 
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